The story of Viagra, initially marketed by copyright, presents a complex case study for stakeholders considering the drug landscape . Despite its groundbreaking success and creation of vast in revenue , the intellectual property end has opened the floodgates for generic medications, substantially reducing earnings prospects . This change raises dou